• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.44% Nasdaq Down 0.42%

    Arrowhead Research Corp. (ARWR)

    -NasdaqGS
    7.43 Up 0.67(9.83%) Apr 1, 4:00PM EDT
    |After Hours : 7.34 Down 0.09 (1.21%) Apr 1, 7:52PM EDT
    Add to Portfolio
    Prev Close:6.77
    Open:6.73
    Bid:7.24 x 100
    Ask:7.40 x 400
    1y Target Est:14.50
    Beta:2.99
    Next Earnings Date:11-May-15ARWR Earnings announcement
    Day's Range:6.60 - 7.44
    52wk Range:4.95 - 18.64
    Volume:2,119,492
    Avg Vol (3m):1,946,700
    Market Cap:407.10M
    P/E (ttm):N/A
    EPS (ttm):-1.38
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ARWRUp 9.83%407.10M
    PENCUp 7.45%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,227.38
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Sep-15) :-1.47
    Quarterly EPS Est (Mar-15) :-0.37
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):-0.63

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arrowhead Research Corporation develops novel drugs to treat intractable diseases in the United States. The company’s principal product candidates comprise ARC-520, an RNAi-based therapeutic that is in Phase IIa clinical trial to treat chroni... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback